Affordable Access

A phase II study of cisplatin and temozolomide in heavily pre-treated patients with temozolomide-refractory high-grade malignant glioma.

Authors
  • Zustovich, Fable
  • Lombardi, Giuseppe
  • Della Puppa, Alessandro
  • Rotilio, Antonino
  • Scienza, Renato
  • Pastorelli, Davide
Type
Published Article
Journal
Anticancer Research
Publisher
International Institute of Anticancer Research
Publication Date
September 2009
Volume
29
Issue
10
Pages
4275–4279
Identifiers
PMID: 19846986
Source
Medline
License
Unknown

Abstract

The combination of temozolomide and cisplatin is safe and moderately effective in the treatment of heavily pre-treated patients with relapsed high-grade glioma refractory to single-agent temozolomide.

Report this publication

Statistics

Seen <100 times